India Remakes Global Innovation
Harvard Business Review
SEPTEMBER 14, 2011
Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. In doing so, Dr Reddy's strengthens its core generic drugs business and boosts the custom manufacturing services it provides to Big Pharma and nimble biotech startups.
9 
Let's personalize your content